Annonaa muricata Linn Leaf Induce Apoptosis in Cancer Cause Virus


Introduction: Now many studies conducted on the drug substance from nature that can serve as an anticancer agent as a potential chemoprevention agent, such as Annona muricata Linn leaf escort chemotherapy, which was flaring. The cancer cell in humans was included the loss of p53 protein function due to mutations in the protein gene. Other causes are that the p53 proteins are not functioning due to an increase in protein misfolding event chaperones and degradation events ubiquitous as binding by viral protein. Method: Cytotoxicity assay performed on 24 well plate micro-cultures. HeLa cells are as 2 × 104 cells in 100 mL in RPMI media. Created control is RPMI and solvent DMSO 0.25%. Cytotoxic Test performed by the method of calculation tryphan blue dye exclusion. Being fasted for 24 hours in the culture medium, then the cells are grown in micro-plate with media plus samples with a non-lethal concentration (LC50) of partition and fractionation Annona muricata Linn leaf. Sampling is performed at 24 hours. Each of these wells is calculated the number of living cells and made the curve of cell number and incubation time. Result: The results showed that HeLa cells are being LC50 partition of leaves Annona muricata Linn in ethyl acetate his cell death rate was higher (2000 μg/ml have 131.89%; 15.625 μg/ml have 11.37%) and in ethanol-distillate water his cell death rate was lower (2000 μg/ml have 35.80%; 15.625 μg/ml have 3.97%). Another results showed that HeLa cells are being LC50 fractionation of leaves Annona muricata Linn in chloroform his cell death rate was higher (2000 μg/ml have 91.86%; 15.625 μg/ml have 2.68%) and in ethyl acetate, his cell death rate was lower (2000 μg/ml have 23.79%; 15.625 <

Share and Cite:

O. Astirin, A. Artanti, M. Fitria, E. Perwitasari and A. Prayitno, " Annonaa muricata Linn Leaf Induce Apoptosis in Cancer Cause Virus," Journal of Cancer Therapy, Vol. 4 No. 7, 2013, pp. 1244-1250. doi: 10.4236/jct.2013.47146.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] G. W. Chang, M. S. H. Wahyuningsih and A. A. A. Yustina, “Effect of Benalu (Dendrophtoe sp.) Leaves Extract on the Male Rat (Rattus Norvegicus) Benzidine Induced Hepatotoxicity,” Journal Kedokteran Yarsi, Vol. 7, No. 1. 1999, pp. 121-132.
[2] D. J. Greenblatt and L. L. von Moltke, “Interaction of Warfarin with Drugs, Natural Substances, and Foods,” Journal of Clinical Pharmacology, Vol. 45, No. 2, 2005, pp. 127-132. doi:10. 1177/0091270004271404
[3] P. Imming, “Molecular Targets of Natural Drug Substances: Idiosyncrasies and Preferences,” Planta Medica, Vol. 76, No. 16, 2010, pp. 1794-1801. doi:10.1055/s-0030-1250236
[4] T. Shan, Q. Ma, K. Guo, J. Liu, W. Li, F. Wang and E. Wu, “Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs,” Current Molecular Medicine, Vol. 11, No. 8, 2011, pp. 666-677.
[5] K. H. Lee, “Anticancer Drug Design Based on PlantDerived Natural Products,” Journal of Biomedical Science, Vol. 6, No. 4, 1999, pp. 236-250.
[6] H. Harada, U. Yamashita, H. Kurihara, E. Fukushi, J. Kawabata and Y. Mamei, “Antitumor Activity of Palmitic Acid Found as a Selective Cytotoxic Substance in a Marine Red Alga,” Anticancer Research, Vol. 22, No. 5, 2002, pp. 2587-2590.
[7] B. V. Pardhasaradhi, M. Reddy, A. M. Ali, A. L. Kumari and A. Khar, “Differential Cytotoxic Effects of Annona Squamosa Seed Extracts on Human Tumour Cell Lines: Role of Reactive Oxygen Species and Glutathione,” Journal Biosciences, Vol. 30, No. 2, 2005, pp. 237-244. doi:10.1007/BF02703704
[8] M. Trubus, “Daun Sirsak vs Chemotherapy (Kanker),” Laporan Utama Majalah Trubus, 2011
[9] A. S. N. Formagio, C. A. L. Kassuya, F. F. Neto, C. R. F. Volobuff, E. K. K. Iriguchi, M. do C. Vieira and M. A. Foglio, “The Flavonoid Content and Antiproliferative, Hypoglycaemic, Anti-Inflammatory and Free Radical Scavenging Activities of Annona dioica St. Hill,” BMC Complementary and Alternative Medicine, Vol. 13, 2013, p. 14. doi:10.1186/1472-6882-13-14
[10] L. Teppo, E. Pukkala and E. Saxen, “Multiple Cancer— An Epidemiologic Exercise in Finland,” Journal of National Cancer Institute, Vol. 75, No. 2, 1985, pp. 207-217.
[11] A. Prayitno, “Cervical Cancer with Human Papilloma Virus and Epstein Barr Virus Positif,” BMC Journal of Carcinogenesis, Vol. 5, 2006, p. 13. doi:10.1186/1477-3163-5-13
[12] D. Subramanya and P. D. Grivas, “HPV and Cervical Cancer: Updates on an Established Relationship,” Postgraduate Medicine, Vol. 120, No. 4, 2008, pp. 7-13. doi:10.3810/pgm.2008.11.1928
[13] J. Samer, Sharkaphaviova, S. Miluska and G. Diana, “Analysis of P53 Status in Human Cell Line Using a Functional Assay in Yeast: Detection of New No Sense p53 Mutattion in Codon 124,” Oncology Report, Vol. 14. 2005, pp. 901-907.
[14] H. F. Chiu, T. T. Chih, Y. M. Hsian, C. H. Tseng, M. J. Wu and Y. C. Wu, “Bullatacin, a Potent Antitumor Annonaceous Acetogenin, Induces Apoptosis through a Reduction of Intracellular cAMP and cGMP Levels in Human Hepatoma 2.2.15 Cells,” Biochemical Pharmacology, Vol. 65, No. 3, 2003, pp. 319-327. doi:10.1016/S0006-2952(02)01554-X
[15] G. Jiebin, O. Hirokazu, O. Shigeki, N. Shinobu and N. Shinji, “Arsenic Trioride Induces Apoptosis in Leukemia and Lymphoma Cell Lines via the CD95/CD95L System,” Oncology Reports, Vol. 10, 2005, pp. 705-709.
[16] S. Haupt, M. Berger, Z. Goldberg and Y. Haupt, “Apoptosis—The p53 Network,” Journal Cell Science, Vol. 116, No. 20, 2003, pp. 4077-4085. doi:10.1242/jcs.00739
[17] A. Vazquez, E. E. Bond, A. J. Levine and G. L. Bond, “The Genetics of the p53 Pathway, Apoptosis and Cancer Therapy,” Nature Review. Drug Discovery, Vol. 7, No. 12, 2008, pp. 979-987. doi:10.1038/ nrd2656
[18] J. D. Amaral, J. M. Xavier, C. J. Steer and C. M. Rodrigues, “The Role of p53 in Apoptosis,” Discovery Medicine, Vol. 9, No. 45, 2010, pp. 145-152.
[19] R. S. Fife, B. T. Rougraff, C. Proctor and G. W. Sledge Jr., “Inhibition of Proliferation and Induction of Apoptosis by Doxycycline in Cultured Human Osteosarcoma Cells,” Journal of Laboratory and Clinical Medicine, Vol. 130, No. 5, 1997, pp. 530-534. doi:10.1016/S0022-2143(97)90130-X
[20] M. P. Mayer and B. Bukau, “Hsp70 Chaperones: Cellular Functions and Molecular Mechanism,” Cellular and Molecular Life Sciences, Vol. 62, No. 6, 2005, pp. 670-684. doi:10.1016/S0022-2143(97)90130-X
[21] C. R. Young and C. J. Welsh, “Stress, Health, and Disease,” Cell Science, Vol. 2, No. 2, 2005, pp. 132-159.
[22] E. H. Vogel, M. E. Castro, P. A. Solar and F. A. Soto, “Enhancement of Pavlovian Conditioned Immunosupression in Rats,” Acta Neurobiologiae Experimentalis, Vol. 67, No. 1, 2007, pp. 71-81.
[23] Y. P. Zhang and Y. Xiong, “A p53 Aminoterminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation,” Science, Vol. 292, No. 5523, 2001, pp. 1910-1915. doi:10.1126/ science.1058637
[24] Y. H. Zhang, H. Y. Peng, G. H. Xia, M. Y. Wang and Y. Han, “Anticancer Effect of Two Diterpenoid Compounds Isolated from Annona glabra Linn,” Acta Pharmacology Singapore, Vol. 25, No. 7, 2004, pp. 937-942.
[25] W. B. Derry, A. P. Putzke and J. H. Rothman, “Caenorhabditis Elegans p53: Role in Apoptosis, Meiosis, and Stress Resistance,” Science, Vol. 294, No. 5542, 2001, pp. 591-595. doi:10.1126/ science.1065486
[26] L. Qu, S. Huang, D. Baltzis, A. M. Rivas-Estilla, O. Pluquet, M. Hatzoglou, C. Koumenis, Y. Taya, A. Yoshimura and A. E. Koromilas, “Endoplasmic Reticulum Stress Induces p53 Cytoplasmic Localization and Prevents p53-Dependent Apoptosis by a Pathway Involving Glycogen Synthase Kinase-3beta,” Genes and Development, Vol. 18, No. 3, 2004, pp. 261-277. doi:10.1101/gad.1165804
[27] J. L. Alberto, M. D. Macario and E. C. de Macario, “Sick Chaperones, Cellular Stress, and Disease,” New England Journal of Medicine, Vol. 353, No. 14, 2005, pp. 1489-1501. doi:10.1056/NEJMra050111
[28] I. M. Ghobrial, T. E. Witzig and A. A. Adjei, “Targeting Apoptosis Pathways in Cancer Therapy,” CA: A Cancer Journal for Clinicians, Vol. 55, No. 3, 2005, pp. 178-194.
[29] A. Prayitno, E. Asnar, O. P. Astirin, D. Rosmala and S. T. Putra, “Heat Shock Protein 40 (Hsp40) and Hsp70 Protein Expression in Oral Squamous Cell Carcinoma (OSCC),” Journal of Cancer Therapy, Vol. 4, No. 3, 2013, pp. 734-741. doi:10.4236/jct.2013.43090
[30] M. Hollstein, D. Sidransky, B. Vogelstein and C. C. Harris, “p53 Mutations in Human Cancers,” Science, Vol. 253, No. 5015, 1991, pp. 49-53.
[31] T. Soussi and G. Lozano, “p53 Mutation Heterogeneity in Cancer,” Biochemical Biophysical Research Communications, Vol. 331, No. 3, 2005, pp. 834-842. doi:10.1016/j.bbrc.2005.03.190
[32] A. Prayitno, R. Darmawan, I. Yuliadi and A. Mudigdo, “The Expression of p53, Rb, and c-myc Protein in Cervical Cancer by Immunohistochemistry Stain,” Biodiversitas, Vol. 6, No. 3, 2005, pp. 157-159.
[33] O. P. Astirin, “Implantasi Pada Rattus Norvegicus Setelah Perlakuan Dengan Actinomycin D,” Thesis, Faculty of Pasca Sarjana, University of Gajah Mada, Yogyakarta, 1991.
[34] F. R. Ian, “Culture of Animal Cells: A Manual of Basic Techniques,” 4th Edition, Wiley-Lies, Canada, 2000.
[35] Gadek, J. Wesierska, V. Kotala, S. Kuchtickova and M. D. Horky, “Induction of Apoptosis in Human Cervic Carcinoma Cells During Therapy by Cisplatin,” International Symposium on Predictive Oncology and Intervention Strategies, Paris, 9-12 February 2002.
[36] B. N. Meyer, N. R. Ferriqni, J. E. Putnam, L. B. Jacobsen, D. E. Nichols and J. L. McLaughlin, “Brine Shrimp: A Convenient General Bioassay for Active Plant Constituents,” Planta Medicine, Vol. 45, No. 5, 1982, pp. 31-34. doi:10.1055/s-2007-971236
[37] Mursyidi and Achmad, “Statistika Farmasi Dan Biologi,” Ghalia, 1985.
[38] N. E. Raab-Traub, “Epstein-Barr Virus in the Pathogenesis of NPC,” Seminars in Cancer Biology, Vol. 12, No. 6, 2002, pp. 431-441. doi:10.1016/S1044579X0200086X
[39] A. P. Feinberg, R. Ohlsson and S. Henikoff, “The Epigenetic Progenitor Origin of Human Cancer,” Nature Reviews. Genetics, Vol. 7, No. 1, 2006, pp. 21-33. doi:10.1038/nrg1748
[40] J. L. Alberto, M. D. Macario and E. C. de Macario, “Sick Chaperones, Cellular Stress, and Disease,” The England Journal of Medicine, Vol. 353, No. 14, 2005, pp. 1489-1501.
[41] C. Jolly and R. I. Morimoto, “Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death,” Journal of the National Cancer Institute, Vol. 92, No. 19, 2000, pp. 1564-1572. doi:10.1093/jnci/92.19.1564
[42] J. Villar, “Heat Shock Protein Gene Expression and Survival in Critical Illness,” Critical Care, Vol. 4, 2000, pp. 2-5. doi:10.1186/cc643
[43] C. C. Liaw, F.-R. Chang, C.-Y. Lin, C.-J. Chou, H.-F. Chiu, M.-J. Wu and Y.-C. Wu, “New Cytotoxic Monotetrahydrofuran Annonaceous Acetogenins from Annona muricata,” Journal of Natural Products, Vol. 65, No. 4, 2002, pp. 470-475. doi:10.1021/np0105578
[44] H. J. Yang, X. Li, N. Zhang, J. W. Chen and M. Y. Wang, “Two New Cytotoxic Acetogenins from Annona squamosa,” Journal of Asian Natural Products Research, Vol. 11, No. 3, 2009, pp. 250-256. doi:10.1080/10286020802682916
[45] Y. L. Yang, K. F. Hua, P. H. Chuang, S. H. Wu, K. Y. Wu, F. R. Chang and Y. C. Wu, “New Cyclic Peptides from the Seeds of Annona squamosa L. and Their AntiInflammatory Activities,” Journal of Agricultural and Food Chemistry, Vol. 56, No. 2, 2008, pp. 386-392. doi:10.1021/jf072594w
[46] Y. C. Wu, Y. C. Hung, F. R. Chang, M. Cosentino, H. K. Wang and K. H. Lee, “Identification of ent-16 beta, 17-Dihydroxykauran-19-oic Acid as an Anti-HIV Principle and Isolation of the New Diterpenoids Annosquamosins A and B from Annona squamosa,” Journal of Natural Products, Vol. 59, No. 6, 1996, pp. 635-671. doi:10.1021/np960416j
[47] M. Kaleem, M. Asif, Q. U. Ahmed and B. Bano, “Antidiabetic and Antioxidant Activity of Annona squamosa Extract in Streptozotocin-Induced Diabetic Rats,” Singapore Medicine Journal, Vol. 47, No. 8, 2006, pp. 670-675.
[48] S. Panda and A. Kar, “Antidiabetic and Antioxidative Effects of Annona squamosa Leaves Are Possibly Mediated through Quercetin-3-O-Glucoside,” BioFactors, Vol. 31, No. 3-4, 2007, pp. 201-210.
[49] A. Jaswanth, P. Ramanathan and K. Ruckmani, “Evaluation of Mosquitocidal Activity of Annona squamosa Leaves against Filarial Vector Mosquito, Culex quinquefasciatus Say,” Indian Journal of Experimental Biology, Vol. 40, No. 3, 2002, pp. 363-365.
[50] P. Shokeen, K. Ray, M. Bala and V. Tandon, “Preliminary Studies on Activity of Ocimum sanctum, Drynaria quercifolia, and Annona squamosa against Neisseria gonorrhoeae,” Sexually Transmitted Diseases, Vol. 32, No. 2, 2005, pp. 106-111. doi:10.1097/01.olq.0000152821.23777.90
[51] P. J. Schupp, C. Kohlert-Schupp, S. Whitefield, A. Engemann, S. Rohde, T. Hemscheidt, J. M. Pezzuto, T. P. Kondratyuk, E.-J. Park, L. Marler, B. Rostama and A. D. Wright, “Cancer Chemopreventive and Anticancer Evaluation of Extracts and Fractions from Marine Macroand Micro-Organisms Collected from Twilight Zone Waters Around Guam,” Natural Product Communications, Vol. 4, No. 12, 2009, pp. 1717-1728.
[52] M. J. Chavan, P. S. Wakte and D. B. Shinde, “Analgesic and Anti-Inflammatory Activity of Caryophyllene oxide from Annona squamosa L. Bark,” Phytomedicine, Vol. 17, No. 2, 2010, pp. 149-151. doi:10.1016/j.phymed.2009.05.016
[53] R. Lobo, K. S. Prabhu, A. Shirwaikar and A. Shirwaikar, “Curcuma zedoaria Rosc. (White Turmeric): A Review of Its Chemical, Pharmacological and Ethnomedicinal Properties,” Journal of Pharmacy and Pharmacology, Vol. 61, No. 1, 2009, pp. 13-21.
[54] Z. Jiang, R.-Y. Chen, Y. Chen and D.-Q. Yu, “Donnaienin, a New Acetogenin Bearing a Hydroxylated Tetrahydrofuran Ring,” Journal of Natural Products, Vol. 61, No. 1, 1998, pp. 86-88. doi:10.1021/ np9703196
[55] W. Anne-Isabelle, R. Hocquemiller, A. Laurens and A. Cavé, “Glaucafilin, an Acetogenin from Annona glauca,” Journal of Phytochemistry, Vol. 44, No. 8, 1997, pp. 1537-1540.
[56] M. J. Rieser, Z. M. Gu, X. P. Fang, L. Zeng, K. V. Wood and J. L. McLaughlin, “Five Novel Mono-Tetrahydrofuran Ring Acetogenins from the Seeds of Annona muricata,” Journal of Natural Products, Vol. 59, No. 2, 1996, pp. 100-108. doi:10.1021/np960037q

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.